Literature DB >> 28847031

Natural Killer Cells in Liver Disease.

Victoria Male1, Kerstin A Stegmann2, Nicholas J Easom2, Mala K Maini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28847031     DOI： 10.1055/s-0037-1603946

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  7 in total

1.  Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis.

Authors:  Zhou Tian; Baojian Hong; Jianzhong Chen; Zhe Tang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

2.  Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery.

Authors:  Xiaoyan Zhang; Jingxin Li; Tiancai Liu; Min Zhao; Baozhu Liang; Hong Chen; Zhen Zhang
Journal:  Dis Markers       Date:  2022-06-25       Impact factor: 3.464

Review 3.  Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.

Authors:  Antonio Sircana; Elena Paschetta; Francesca Saba; Federica Molinaro; Giovanni Musso
Journal:  Int J Mol Sci       Date:  2019-04-09       Impact factor: 5.923

4.  The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.

Authors:  Antonia O Cuff; Francesca Sillito; Simone Dertschnig; Andrew Hall; Tu Vinh Luong; Ronjon Chakraverty; Victoria Male
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

Review 5.  Liver-Mediated Adaptive Immune Tolerance.

Authors:  Meijuan Zheng; Zhigang Tian
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

6.  Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy.

Authors:  Zhenhuan Cao; Sha Meng; Yanhong Zheng; Junli Wang; Rui Wang; Xinyue Chen
Journal:  Innate Immun       Date:  2020-08-09       Impact factor: 2.680

Review 7.  Cellular based immunotherapy for primary liver cancer.

Authors:  Yuanyuan Zheng; Yan Li; Jiao Feng; Jingjing Li; Jie Ji; Liwei Wu; Qiang Yu; Weiqi Dai; Jianye Wu; Yingqun Zhou; Chuanyong Guo
Journal:  J Exp Clin Cancer Res       Date:  2021-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.